Catalent, Inc. (CTLT) [Rocket]

In millions, except per share items	Jun-30-22	Jun-30-21	Jun-30-20	Jun-30-19	Jun-30-18	Jun-30-17	Jun-30-16	Jun-30-15
	10-K/A	10-K/A	10-K/A	10-K	10-K	10-K	10-K	10-K
Revenues:
Softgel and Oral Technologies				1,039.0	1,114.5
Biologics	2,534.0	1,938.0	1,032.0	573.0	437.0
Oral and Specialty Drug Delivery				598.0	503.3
Other	2,268.0	2,060.0	2,062.0	308.0	408.6
Total revenues	4,802.0	3,998.0	3,094.0	2,518.0	2,463.4	2,075.4	1,848.1	1,830.8
Revenue growth [+]	20.1%	29.2%	22.9%	2.2%	18.7%	12.3%	0.9%	0.2%
Softgel and Oral Technologies				-6.8%
Biologics	30.8%	87.8%	80.1%	31.1%
Oral and Specialty Drug Delivery				18.8%
Clinical Supply Services				-25.2%	23.4%	13.4%	6.6%	-1.1%
Cost of goods sold	3,188.0	2,646.0	2,111.0	1,713.0	1,710.8	1,420.8	1,260.5	1,215.5
Gross profit	1,614.0	1,352.0	983.0	805.0	752.6	654.6	587.6	615.3
Gross margin	33.6%	33.8%	31.8%	32.0%	30.6%	31.5%	31.8%	33.6%
Selling, general and administrative	844.0	687.0	577.0	512.0	464.8	402.6	358.1	337.3
Other operating expenses	29.0	-355.0	7.0	2.0	3.2	1.3	30.0	20.9
EBITDA [+]	1,119.0	1,309.0	653.0	520.0	474.7	397.2	340.1	397.9
EBITDA growth	-14.5%	100.5%	25.6%	9.5%	19.5%	16.8%	-14.5%	-5.3%
EBITDA margin	23.3%	32.7%	21.1%	20.7%	19.3%	19.1%	18.4%	21.7%
Depreciation	255.0	196.0	165.0	141.0	127.5	102.2	94.2	94.3
EBITA	864.0	1,113.0	488.0	379.0	347.2	295.0	245.9	303.6
EBITA margin	18.0%	27.8%	15.8%	15.1%	14.1%	14.2%	13.3%	16.6%
Amortization of intangibles	123.0	93.0	89.0	88.0	62.6	44.3	46.4	46.5
EBIT [+]	741.0	1,020.0	399.0	291.0	284.6	250.7	199.5	257.1
EBIT growth	-27.4%	155.6%	37.1%	2.2%	13.5%	25.7%	-22.4%	-7.3%
EBIT margin	15.4%	25.5%	12.9%	11.6%	11.6%	12.1%	10.8%	14.0%
Non-recurring items [+]	11.0	192.0	5.0	17.0	15.7	16.5	-18.3	-2.8
Asset impairment	10.0	10.0	6.0	14.0	10.2	8.0	-2.7	-4.7
Loss (gain) on disposal of assets	1.0	182.0	-1.0
Interest expense	123.0	110.0	126.0	111.0	111.4	90.1	88.5	105.0
Interest expense	123.0	110.0	126.0	111.0	111.4	90.1	88.5	105.0
Other income (expense), net	-28.0	-3.0	-8.0	-3.0	-5.5	-8.5	15.6	-42.4
Pre-tax income	579.0	715.0	260.0	160.0	152.0	135.6	144.9	112.5
Income taxes	80.0	130.0	39.0	23.0	68.4	25.8	33.7	-97.7
Tax rate	13.8%	18.2%	15.0%	14.4%	45.0%	19.0%	23.3%
Minority interest							-0.3	-1.9
Earnings from continuing ops	483.0	529.0	173.0	132.0	83.6	109.8	111.5	212.1
Earnings from discontinued ops								0.1
Net income	483.0	529.0	173.0	132.0	83.6	109.8	111.5	212.2
Net margin	10.1%	13.2%	5.6%	5.2%	3.4%	5.3%	6.0%	11.6%

Basic EPS [+]	$2.74	$3.15	$1.15	$0.92	$0.64	$0.88	$0.89	$1.77
Growth	-12.8%	173.0%	25.8%	43.9%	-27.5%	-1.7%	-49.6%	261.7%
Diluted EPS [+]	$2.71	$3.11	$1.14	$0.90	$0.63	$0.87	$0.89	$1.75
Growth	-12.8%	173.4%	25.9%	44.1%	-27.6%	-2.2%	-49.3%	261.6%

Dividends per share [+]	$0.02	$0.13	$0.24
Growth	-82.6%	-45.4%

Shares outstanding (basic) [+]	176.0	168.0	150.0	144.0	131.2	125.0	124.8	119.6
Growth	4.8%	12.0%	4.2%	9.7%	5.0%	0.1%	4.4%	59.3%
Shares outstanding (diluted) [+]	178.0	170.0	152.0	146.0	133.2	126.7	125.9	121.3
Growth	4.7%	11.8%	4.1%	9.6%	5.1%	0.7%	3.7%	59.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.